Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.055 | 0.7 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.046 | 0.7 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |